Comparison of Two Multifocal Contact Lenses Worn on a Daily Disposable Basis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01254760

Recruitment Status : Completed

First Posted : December 7, 2010

Results First Posted : February 17, 2012

Last Update Posted : July 10, 2012

Sponsor:

Information provided by (Responsible Party):

Alcon Research ( CIBA VISION )

Study Description

Brief Summary:

The purpose of this trial is to evaluate and compare the clinical performance of two multifocal contact lenses.

Condition or disease	Intervention/treatment	Phase
Presbyopia Myopia	Device: Nelfilcon A multifocal contact lens, investigational Device: Nelfilcon A multifocal contact lens, commercial	Not Applicable

Study Design


Study Type :	Interventional (Clinical Trial)
Actual Enrollment :	79 participants
Allocation:	Randomized
Intervention Model:	Crossover Assignment
Masking:	Single (Participant)
Primary Purpose:	Treatment
Study Start Date :	December 2010
Actual Primary Completion Date :	January 2011
Actual Study Completion Date :	January 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eye Wear

U.S. FDA Resources

Arms and Interventions

Arm	Intervention/treatment
Investigational multifocal / Commercial multifocal Investigational multifocal contact lenses worn first, with commercial multifocal contact lenses worn second. Each product worn bilaterally on a daily wear, daily disposable basis for 5 days.	Device: Nelfilcon A multifocal contact lens, investigational Investigational, soft, multifocal contact lens for daily wear, daily disposable use. Device: Nelfilcon A multifocal contact lens, commercial Commercially marketed, soft, multifocal contact lens FDA-approved for daily wear, daily disposable use. Other Name: Focus® DAILIES® Progressive
Commercial multifocal / Investigational multifocal Commercial multifocal contact lenses worn first, with investigational multifocal contact lenses worn second. Each product worn bilaterally on a daily wear, daily disposable basis for 5 days.	Device: Nelfilcon A multifocal contact lens, investigational Investigational, soft, multifocal contact lens for daily wear, daily disposable use. Device: Nelfilcon A multifocal contact lens, commercial Commercially marketed, soft, multifocal contact lens FDA-approved for daily wear, daily disposable use. Other Name: Focus® DAILIES® Progressive

Outcome Measures

Primary Outcome Measures :

End of Day Comfort [ Time Frame: 5 days of wear, lenses replaced daily ]
End of day comfort was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. End of day comfort was measured on a 10-point scale, with 1 being poor and 10 being excellent.
End of Day Dryness [ Time Frame: 5 days of wear, lenses replaced daily ]
End of day dryness was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. End of day dryness was measured on a 10-point scale, with 1 being very dry and 10 being not dry.
Handling at Removal [ Time Frame: 5 days of wear, lenses replaced daily ]
Handling at removal was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. Handling at removal was measured on a 10-point scale, with 1 being poor/difficult and 10 being excellent/easy.
Overall Vision [ Time Frame: 5 days of wear, lenses replaced daily ]
Overall vision was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. Overall vision was measured on a 10-point scale, with 1 being poor and 10 being excellent.

Secondary Outcome Measures :

Overall Fit [ Time Frame: Day 5, lenses replaced daily ]
Overall lens fit was assessed by the investigator at study visit using a biomicroscope, which magnifies the appearance of the contact lens on the participant's eye. Lens fit was assessed by eye and graded on a 5-point scale, with 2=unacceptably loose, 1= acceptably loose, 0=optimal, -1=acceptably tight, and -2=unacceptably tight

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	41 Years to 68 Years (Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Age 41 to 68 (inclusive).
Spectacle add between +0.75 and +2.75D (inclusive).
Habitual spectacle prescription ≤ 1.00DC (cyl).
Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

Eye injury or surgery within twelve weeks of enrollment.
Pre-existing ocular irritation that would preclude contact lens fitting.
Currently enrolled in a clinical trial.
Prior refractive surgery.
Other protocol-defined exclusion criteria may apply.

Contacts and Locations

No Contacts or Locations Provided

More Information


Responsible Party:	CIBA VISION
ClinicalTrials.gov Identifier:	NCT01254760 History of Changes
Other Study ID Numbers:	P-416-C-001 Sub 04
First Posted:	December 7, 2010 Key Record Dates
Results First Posted:	February 17, 2012
Last Update Posted:	July 10, 2012
Last Verified:	January 2012

Additional relevant MeSH terms:


Presbyopia Refractive Errors Eye Diseases

To Top